Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Gynecologic Oncology
|
August 21, 2025
Emerging approaches to enhance immune responses in ovarian cancer: 15th biennial Rivkin Center Ovarian Cancer Research Symposium
Nan Zhang, Rebecca L Porter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2021
Checkpoint Blockade: Not Yet NINJA Status in Ovarian Cancer
Rebecca L Porter, Ursula A Matulonis
Cell Stem Cell
|
March 7, 2009
Key endothelial signals required for hematopoietic recovery
Rebecca L Porter, Laura M Calvi
Expert Review of Anticancer Therapy
|
July 17, 2023
Mirvetuximab soravtansine for platinum-resistant epithelial ovarian cancer
Rebecca L Porter, Ursula A Matulonis
Cold Spring Harbor Perspectives in Medicine
|
May 19, 2025
Ovarian Cancer Therapy
Diana Miao, Ursula A Matulonis, Rebecca L Porter
Child Welfare
|
March 2, 2010
Improving the retention of child welfare workers by strengthening skills and increasing support for supervisors
Lynette M Renner, Rebecca L Porter, Steven Preister
Current Opinion in Supportive and Palliative Care
|
August 8, 2008
Hematopoietic niche and bone meet
Benjamin J Frisch, Rebecca L Porter, Laura M Calvi
Blood
|
May 19, 2012
Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells
Olga Bromberg, Benjamin J Frisch, Jonathan M Weber, et al.
Blood
|
November 23, 2007
Enucleation of primitive erythroid cells generates a transient population of "pyrenocytes" in the mammalian fetus
Kathleen E McGrath, Paul D Kingsley, Anne D Koniski, et al.
Science (New York, N.Y.)
|
March 26, 2011
Clr4/Suv39 and RNA quality control factors cooperate to trigger RNAi and suppress antisense RNA
Ke Zhang, Tamas Fischer, Rebecca L Porter, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Gynecologic Oncology
|
August 21, 2025
Emerging approaches to enhance immune responses in ovarian cancer: 15th biennial Rivkin Center Ovarian Cancer Research Symposium
Nan Zhang, Rebecca L Porter
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 16, 2021
Checkpoint Blockade: Not Yet NINJA Status in Ovarian Cancer
Rebecca L Porter, Ursula A Matulonis
Cell Stem Cell
|
March 7, 2009
Key endothelial signals required for hematopoietic recovery
Rebecca L Porter, Laura M Calvi
Expert Review of Anticancer Therapy
|
July 17, 2023
Mirvetuximab soravtansine for platinum-resistant epithelial ovarian cancer
Rebecca L Porter, Ursula A Matulonis
Cold Spring Harbor Perspectives in Medicine
|
May 19, 2025
Ovarian Cancer Therapy
Diana Miao, Ursula A Matulonis, Rebecca L Porter
Child Welfare
|
March 2, 2010
Improving the retention of child welfare workers by strengthening skills and increasing support for supervisors
Lynette M Renner, Rebecca L Porter, Steven Preister
Current Opinion in Supportive and Palliative Care
|
August 8, 2008
Hematopoietic niche and bone meet
Benjamin J Frisch, Rebecca L Porter, Laura M Calvi
Blood
|
May 19, 2012
Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells
Olga Bromberg, Benjamin J Frisch, Jonathan M Weber, et al.
Blood
|
November 23, 2007
Enucleation of primitive erythroid cells generates a transient population of "pyrenocytes" in the mammalian fetus
Kathleen E McGrath, Paul D Kingsley, Anne D Koniski, et al.
Science (New York, N.Y.)
|
March 26, 2011
Clr4/Suv39 and RNA quality control factors cooperate to trigger RNAi and suppress antisense RNA
Ke Zhang, Tamas Fischer, Rebecca L Porter, et al.
Page
of 3